AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 156 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $713,000 | -47.0% | 20,702 | -74.3% | 0.01% | -44.4% |
| Q2 2020 | $1,345,000 | -76.4% | 80,514 | -70.5% | 0.01% | -71.9% |
| Q3 2019 | $5,706,000 | +8815.6% | 272,536 | +9509.9% | 0.03% | – |
| Q1 2019 | $64,000 | -99.4% | 2,836 | -99.0% | 0.00% | -100.0% |
| Q4 2017 | $11,219,000 | – | 296,651 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|